肝缺血再灌注后HSP70 mRNA的表达及其与凋亡关系的临床研究

摘要/Abstract

摘要： 目的通过检测肝组织在缺血再灌注后HSP70 mRNA的表达及细胞凋亡情况,探讨肝组织对缺血再灌注的反应及HSP70mRNA与肝细胞凋亡之间的关系。为选用有效的预处理方法、抑制细胞凋亡、减轻肝脏缺血再灌注损伤提供理论基础。方法术中在肝门阻断前、肝门阻断后开放时和手术结束关腹前各取切缘旁肝组织10g。原位杂交法检测肝组织中HSP70 mRNA的表达;脱氧核糖核苷酸末端转移酶介导的缺口末端标记法(TUNEL)检测肝细胞的凋亡情况。结果①肝门阻断前肝组织HSP70 mRNA在每高倍视野下阻性细胞数为1.90±0.84;肝门开放时为24.4±5.7;关腹前为35.7±5.7,3组阳性细胞数比较差异有统计学意义(P<0.05);两两比较差异有统计学意义(P<0.05)。②肝门阻断前肝细胞凋亡指数为(11.4±2.4)‰;肝门开放时为(9.8±1.7)‰;关腹前为(8.6±1.6)‰。肝门阻断前肝细胞的凋亡指数高于肝门开放时肝细胞的凋亡指数(P<0.05)、高于关腹前肝细胞的凋亡指数(P<0.05);肝门开放时肝细胞的凋亡指数高于关腹前肝细胞的凋亡指数(P<0.05)。③肝组织中HSP70 mRNA的表达与肝细胞凋亡指数呈负相关。结论①在正常肝组织中几乎无HSP70 mRNA的表达,术中肝缺血再灌注后的肝组织中HSP70 mRNA有较高的表达,且呈上升趋势,提示HSP70与HIRI的发生和发展有一定关系。②肝门阻断开放后肝组织HSP70 mRNA的表达增加,肝细胞凋亡指数减少,两者呈负相关。提示HSP70具有一定的抑制细胞凋亡作用,HSP70作为一种保护性因素对机体及肝功能的恢复起到一定作用。

关键词: 肝脏, 缺血再灌注, HSP70 mRNA, 细胞凋亡

Abstract: Objective To detect the response of hepatic tissue to ischemic reperfusion and the relationship between the expression of HSP70 mRNA and apoptosis.And then to provide a theoretical basis for selecting effective pretreatment method,inhibiting apoptosis and reducing the hepatic injury by ischemic reperfusion.Methods liver tissue(10g for each) was taken around incisal margin before the blockage of porta hepatis,the open of porta hepatis and before the closure of abdominal cavity, respectively.In situ hybridization was used to detect the expression of HSP70 mRNA.Terminal deoxynucleotidyl transferase mediated dUTP nick end labeling was used to detect the apoptosis in hepatic tissue.Results①The numbers of positive cell of HSP70 mRNA expression in the pre-blockage of porta hepatis group,the open of porta hepatis group and the pre-closure of abdominal cavity group was 1.90±0.84,24.4±5.7 and 35.1±5.1 respectively.Differences among these three groups were significant(P<0.05).②The AI(apoptosis index) of hepatic tissue in the pre-blockage of porta hepatis group,the open of porta hepatis group and the pre-closure of abdominal cavity group was(11.4±2.4)‰,(9.8±1.7)‰and(8.6±1.6)‰respectively.AI in the pre-blockage of porta hepatis group was more than that in the open of porta hepatis group and the preclosure of abdominal cavity group(P<0.05).AI in the open of porta hepatis group was more than that in the pre-closure of abdominal cavity group(P<0.05).Conclusions①There is little expression of HSP70 mRNA in the normal hepatic tissue, while there is high expression in hepatic ischemic reperfusion injury(HIRI).It suggests that there is some relationship between HSP70 and HIRI.②In the open of porta heptis group,there is a negative correlation between the increased expression of HSP70 mRNA and the decreased of AI,which suggests HSP70 has an effect on suppressing apoptosis.

Key words: Liver, Ischemic reperfusion, HSP70 mRNA

郭雅;段佳佳;文张;宋经青;黎乐群;. 肝缺血再灌注后HSP70 mRNA的表达及其与凋亡关系的临床研究[J]. 中国癌症防治杂志, 2009, 1(02): 114-116.

GUO Ya,DUAN Jia-jia,WEN Zhang,et al.. Clinical study on expression of HSP70 mRNA in hepatic ischemic reperfusion injury and its relationship with apoptosis[J]. Chinese Journal of Oncology Prevention and Treatment, 2009, 1(02): 114-116.

参考文献

1 Kume M,Yamamoto Y,Saad S,et al.Ischemic pre-conditioning of the liver in rats:implications of heat shock protein induction to increase tolerance of ischemiareperfusion injury[J].J Lab Clin Med,1996,128 3:251-258. 2 Nomura F,Aoki M,Forbess J,et al.Myocardial self-preservative elect of heat shock protein70 on an immature lamb heart[J].Ann-Thorac Surg,1999, 68:1736. 3 Zacharow S,Frank S,Otto M,et al.Lipoteichoic acid induce delayed protection in the rat heart:A comparison with endotox in[J].Arterioscler Thromb Vasc Biol, 2000,20(6):1521-28. 4 Wu S,Li HY,Wong TM.Cardioprotection of preconditioning by metabolic inhibi- tion in the rat ventricular myocyte involvement of k-opioidreceptor[J].Clir Res, 1999,84(12):1388-95. 5 Matsumoto K,Honda K,Kobayashi N,et al.Protective effect of heat preconditioning of rat liver graft rceulting in improved transplant survival[J].Transplantation, 2001,71(7):862-868. 6邹伟,史榕荇,于学平.针刺对急性高血压脑出血大鼠Hsp70 mRNA表达的调整作用[J].中医药学报,2003,31(1):46. 7 Matsumoto K,Honda K,Kobayashi N,et al.Protective effect of heat preconditioning of rat liver graft resulting in improved transplant survival[J].Transplantation, 2001,71(7):862-868. 8 Chen H,Yu YY,Zhang M J,et al.Protective effect of doxorubicin induced heat shock protein 72 on cold preservation injury of rat livers[J].World J Gastroenterol, 2004,10:1375-78. 9 Zhang R,Bai L,Streb JW,et al.Thioredoxin-2 inhibits Mitochondria located ASK1 mediated apoptosis in a JNK independent Manner[J].Circ Res,2004,94 11: 1483-91. 10 Wullaert A,Heyninck K,Beyaert R,et al.Mechanisms of crosstalk between TNF-induced NF-B and JNK activation in hepatocytes[J].Biochem Pharmacol, 2006,72:1090-1101. 11 Didelot C,Schmitt E,Brunet M,et al.Heart shock proteins:endogenous modulators of apoptotic cell death[J].Handb Exp Pharmacol,2006,171-198. 12 Compagnon P,Lindell S,Ametani MS,et al.Ischemicprecondition-ing and liver tolerance to warm or cold is chemia:experimental studies inlarge animals[J]. Transplantation,2005,79(10):1393-400.

[1]	李磊, 刘晓丹, 周凯翔, 和林洁, 张健, 陈强, 孟涵, 冯欢, 张文明, 卢骏, 周峰, 崔洪尊, 牛万成, 张召辉. 缺血后处理对大鼠线粒体功能的影响及在肝脏缺血再灌注损伤中的保护机制[J]. 中国癌症防治杂志, 2025, 17(1): 48-54.
[2]	贺紫云, 王昊伦, 范倩青, 刘志辉. 锰离子对肝癌细胞增殖及凋亡的影响[J]. 中国癌症防治杂志, 2024, 16(1): 62-66.
[3]	刘思阳, 唐恩雨, 徐广全. 耐药持久性癌细胞调控机制及治疗策略的研究进展[J]. 中国癌症防治杂志, 2023, 15(2): 235-239.
[4]	陈朝梅, 奚敏, 施秀, 王芳, 周金华. 沉默G6PD对卵巢癌细胞顺铂敏感性的影响及其作用机制[J]. 中国癌症防治杂志, 2022, 14(3): 274-280.
[5]	陈雪欣, 王一倩. 白细胞介素-33对急性髓系白血病细胞株HL-60、NB4凋亡和周期的调控作用及机制研究[J]. 中国癌症防治杂志, 2021, 13(6): 613-617.
[6]	王梓萌, 向作林 . 立体定向放射治疗肝脏转移瘤的临床疗效[J]. 中国癌症防治杂志, 2021, 13(6): 641-646.
[7]	储文梅, 熊旭东, 何淼, 计高荣, 陈莉云, 童佳, 张卓成, 李黎. 白藜芦醇对人胃癌耐药细胞SGC-7901/5-FU生物学效应的影响及其作用机制[J]. 中国癌症防治杂志, 2021, 13(3): 231-236.
[8]	胡啸吟, 张杰, 赵婧菲, 詹国华, 李远宽, 向邦德 . 六种分期系统预测AFP阴性肝细胞癌患者术后预后价值的比较[J]. 中国癌症防治杂志, 2021, 13(2): 190-194.
[9]	王安荣, 王强. 钆塞酸二钠增强MRI在定量肝功能评估的应用现状[J]. 中国癌症防治杂志, 2021, 13(1): 94-98.
[10]	郭世奎, 张剑, 李锦媛, 包维民, 张鹏, 黄映光, 凌平, 王勇志, 赵泉. 高脂饮食对结肠癌肝脏转移的影响及作用机制[J]. 中国癌症防治杂志, 2020, 12(1): 28-33.
[11]	韩乐, 许彪. 微管及其靶向制剂在骨肉瘤细胞凋亡中的研究进展[J]. 中国癌症防治杂志, 2019, 11(5): 442-446.
[12]	刘丽文,阳志军,俸艳英. 缬沙坦对阿霉素所致心肌细胞损伤保护作用的初步研究[J]. 中国癌症防治杂志, 2018, 10(1): 19-23.
[13]	王强,马宽生. ALPPS在原发性肝癌治疗中的应用现状[J]. 中国癌症防治杂志, 2017, 9(6): 442-446.
[14]	赵卫华,程鹏. 死亡相关蛋白激酶与血液系统肿瘤的研究进展[J]. 中国癌症防治杂志, 2017, 9(5): 408-411.
[15]	马良,苏奇斌,王言焱,朱少亮,赵新华,游雪梅,向邦德,黎乐群. 加速康复外科在肝脏外科围手术期的应用现状与争论[J]. 中国癌症防治杂志, 2017, 9(3): 236-240.